EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting Non-Coding RNAs as a Potential Therapeutic and Delivery Strategy Against Neurodegenerative Diseases

Anastasia Bougea iD

International Journal of Molecular Sciences · 03.04.2026 · 27 (7) · 3260

DOI: 10.3390/ijms27073260 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.04.2026. Verfasst von Anastasia Bougea. Beteiligte Einrichtung: Medical School, National and Kapodistrian University of Athens, M. Asias 75, 11574 Athens, Greece. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, RNA, Untranslated. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 166 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurodegenerative diseases (NDs), including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and amyotrophic lateral sclerosis (ALS), represent a growing global health challenge characterized by progressive neuronal loss and a lack of definitive disease-modifying treatments. This review explores the emerging potential of targeting non-coding RNAs (ncRNAs), such as microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and exosomal RNAs, to modulate pathogenic molecular pathways and address the underlying molecular origins of neurodegeneration. We evaluate the integration of advanced computational techniques for RNA structure prediction and gene regulatory network analysis, alongside chemical engineering strategies—such as Locked Nucleic Acids (LNAs) and phosphorothioate modifications—aimed at enhancing the stability and specificity of RNA-based molecules. Furthermore, we analyze cutting-edge delivery and editing technologies, including nanotechnology-driven solutions for precise neuronal targeting and the CRISPR/Cas13 system for direct ncRNA manipulation.The findings indicate that while challenges in delivery efficiency and long-term efficacy persist, the synergy of chemical engineering and computational modeling significantly improves the therapeutic profile of ncRNAs, with exosomal pathways offering a novel route for intercellular signaling modulation and biomarker discovery. Therapeutic interventions directed at specific clinical targets, such as miR-34a and BACE1-AS, demonstrate the capacity to influence protein aggregation and neuroinflammatory cascades. Although ncRNA-based therapies are currently in nascent stages, ongoing technological advancements in RNA editing and nanotechnology offer a transformative framework that could redefine the future of ND treatment and successfully halt disease progression rather than merely managing symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurodegenerative DiseasesRNA, UntranslatedHumansAnimalsMicroRNAsExosomesCRISPR-Cas SystemsRNA, Long Noncoding

Stichwörter der Autor:innen

CRISPR/Cas13RNA therapeuticsblood–brain barrierexosomesgene regulationnanotechnologyncRNAneurodegenerative diseasesnon-coding RNAsprecision medicine

Substanzen

MicroRNAsRNA, UntranslatedRNA, Long Noncoding

Autor:innen und Institutionen

  • Medical School, National and Kapodistrian University of Athens, M. Asias 75, 11574 Athens, Greece.

ORCID-Profile: Anastasia Bougea

Zitieren

APA

Bougea, A. (2026). Targeting Non-Coding RNAs as a Potential Therapeutic and Delivery Strategy Against Neurodegenerative Diseases. International Journal of Molecular Sciences, 27(7), 3260. https://doi.org/10.3390/ijms27073260

Vancouver

Bougea A. Targeting Non-Coding RNAs as a Potential Therapeutic and Delivery Strategy Against Neurodegenerative Diseases. International Journal of Molecular Sciences. 2026;27(7):3260. doi:10.3390/ijms27073260

BibTeX
@article{Bougea2026,
  author = {Bougea, Anastasia},
  title = {Targeting Non-Coding RNAs as a Potential Therapeutic and Delivery Strategy Against Neurodegenerative Diseases},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {7},
  pages = {3260},
  doi = {10.3390/ijms27073260}
}
Kostenlos starten →